{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "W",
          "alt": "X",
          "position": "437"
        },
        "variant_string_id": "PINK1 W437X"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The patient’s ﬁbroblast mitochondria exhibited a lower respiratory activity and a decreased respiratory control ratio with cellular ATP supply relying mainly on enhanced glycolytic production.",
          "judgment": "Yes",
          "reasoning": "The study employed patient-derived fibroblasts (abnormal) in comparison to normal fibroblasts (wild type control).",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The quantity, specific activity and subunit pattern of the oxidative phosphorylation complexes were normal.",
          "judgment": "No",
          "reasoning": "The study did not explicitly use known pathogenic or benign variants as controls for this specific assay.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence is supporting because the study compared patient fibroblasts to control fibroblasts, demonstrating a pathological phenotype in the patient’s mitochondria. However, a lack of explicit pathogenic or benign variant controls limits the strength of the functional evidence."
    }
  ]
}